Correvio Pharma Stock Price - CORV

-0.0015 (-0.36%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Correvio Pharma Corporation CORV NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0005 0.12% 0.4165 0.415 0.4189 0.416 0.416 00:00:02
Bid Price Ask Price Spread Spread % News
0.411 5.70 5.29 92.79% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,465 1,839,680 $ 0.417051 $ 767,240 2,471,430 0.21 - 3.42
Last Trade Time Type Quantity Stock Price Currency
19:54:05 formt 847 $ 0.415 USD

Correvio Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 27.57M 66.19M 39.81M $ 32.63M $ - -0.46 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Correvio Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CORV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.41850.4320.40370.41649481,654,191-0.002-0.48%
1 Month0.40530.4320.36320.40596242,526,3230.01122.76%
3 Months0.5610.77660.280.40716155,183,834-0.1445-25.76%
6 Months2.202.500.210.46204855,308,434-1.78-81.07%
1 Year2.513.420.210.50288612,712,976-2.09-83.41%
3 Years4.,022,022-3.83-90.2%
5 Years9.1910.400.210.9075189642,215-8.77-95.47%

Correvio Pharma Description

Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial Fibrillation, Hospital Acquired Pneumonia & Community Acquired Pneumonia, Pulmonary Arterial Hypertension, and Supraventricular Tachycardia. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.